You're reading the free version. Trader adds the live tape and alerts.
Start tracking
INBX Buy Disclosure
Lappe Mark · SEC Form 4 · Filed Sep 8, 2026
Buy
Calculated transaction value
$117.84K
Lappe Mark Chief Executive Officer
INBX
Inhibrx Biosciences
INBX
Transaction date
Sep 8, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed same day
INBX daily price context
Close on/before transaction
$114.34
Sep 8, 2026
First close after public filing
$112.86
Sep 9, 2026
30-day return after filing
-17.81%
Through Oct 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,100 shares @ $107.12
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001366074-26-000002
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$2.65M
Buys / sales
6 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Inhibrx Biosciences, Inc. INBX | Buy | Sep 8, 2026 | $1.09M |
| Inhibrx Biosciences, Inc. INBX | Buy | Sep 8, 2026 | $585.34K |
| Inhibrx Biosciences, Inc. INBX | Buy | Sep 8, 2026 | $664.72K |
| Inhibrx Biosciences, Inc. INBX Current | Buy | Sep 8, 2026 | $117.84K |
| Inhibrx Biosciences, Inc. INBX | Buy | Sep 8, 2026 | $54.12K |
| Inhibrx Biosciences, Inc. INBX | Buy | Sep 8, 2026 | $136.38K |